lisinopril / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 124 Diseases   24 Trials   24 Trials   2082 News 


«12...14151617181920212223242526»
  • ||||||||||  lisinopril / Generic mfg.
    Trial completion, Trial primary completion date:  The VALIDATE-D Study (clinicaltrials.gov) -  Feb 2, 2016   
    P=N/A,  N=40, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Mar 2017 Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Dec 2015
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date, Surgery:  Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery (clinicaltrials.gov) -  Dec 4, 2015   
    P4,  N=300, Enrolling by invitation, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Enrolling by invitation | Initiation date: Oct 2015 --> Jun 2015 | Trial primary completion date: Jan 2016 --> Apr 2016
  • ||||||||||  lisinopril / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  PIL-FAST: Paramedic Initiated Lisinopril For Acute Stroke Treatment (clinicaltrials.gov) -  Oct 8, 2015   
    P1,  N=14, Completed, 
    N=15000 --> 18000 Recruiting --> Completed | N=60 --> 14 | Trial primary completion date: Sep 2011 --> Dec 2011
  • ||||||||||  Herceptin (trastuzumab) / Roche
    Enrollment closed, Trial primary completion date, Adverse events:  Lisinopril or Coreg CR (clinicaltrials.gov) -  Jul 9, 2015   
    P2,  N=468, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Dec 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Jul 2017
  • ||||||||||  Bystolic (nebivolol) / Menarini, AbbVie
    Trial primary completion date:  FINE-PATH: Non-invasive Haemodynamic Assessment in Hypertension (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=140, Recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2015 --> Sep 2015
  • ||||||||||  Trial completion:  HALT Progression of Polycystic Kidney Disease Study B (clinicaltrials.gov) -  Mar 10, 2015   
    P3,  N=486, Completed, 
    N=40 --> 0 Active, not recruiting --> Completed
  • ||||||||||  losartan / Generic mfg., lisinopril / Generic mfg.
    Trial completion:  VA NEPHRON-D: Diabetes iN Nephropathy Study (clinicaltrials.gov) -  Mar 3, 2015   
    P3,  N=1448, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial completion:  HALT Progression of Polycystic Kidney Disease Study A (clinicaltrials.gov) -  Feb 27, 2015   
    P3,  N=558, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  lisinopril / Generic mfg.
    Trial primary completion date:  ACSRD: Renal Denervation in Patients After Acute Coronary Syndrome (clinicaltrials.gov) -  Feb 26, 2015   
    P2,  N=80, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Jun 2015
  • ||||||||||  lisinopril / Generic mfg.
    New P4 trial:  Drug to Prevent Pneumonia in the Tube Fed (clinicaltrials.gov) -  Feb 9, 2015   
    P4,  N=93, Terminated, 
  • ||||||||||  Trial initiation date, Trial primary completion date, Surgery:  Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery (clinicaltrials.gov) -  Dec 5, 2014   
    P4,  N=300, Not yet recruiting, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Initiation date: Oct 2012 --> Oct 2015 | Trial primary completion date: Jan 2014 --> Jan 2016
  • ||||||||||  candesartan cilexetil / Generic mfg., lisinopril / Generic mfg.
    Enrollment open:  CALIBREX: CAndesartan vs LIsinopril Effects on the BRain (clinicaltrials.gov) -  Nov 11, 2014   
    P3,  N=140, Recruiting, 
    Initiation date: Oct 2012 --> Oct 2015 | Trial primary completion date: Jan 2014 --> Jan 2016 Not yet recruiting --> Recruiting
  • ||||||||||  atenolol / Generic mfg., lisinopril / Generic mfg.
    Trial completion:  Hypertension in Hemodialysis Patients (Aim 3) (clinicaltrials.gov) -  Sep 29, 2014   
    P3,  N=200, Completed, 
    Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Dec 2012 --> Jun 2014 Active, not recruiting --> Completed
  • ||||||||||  candesartan cilexetil / Generic mfg., lisinopril / Generic mfg.
    Trial initiation date:  CALIBREX: CAndesartan vs LIsinopril Effects on the BRain (clinicaltrials.gov) -  May 5, 2014   
    P3,  N=140, Not yet recruiting, 
    Active, not recruiting --> Recruiting Initiation date: Feb 2014 --> Jul 2014